CEACAM6 and lung disorder: We speculate that this species difference for relative level of CEACAM6 in surfactant and supernatant fractions reflects in part the higher amount of alveolar/airway CEACAM6 in infants with lung disease, compared to healthy CEABAC mice, and limited CEACAM6 binding capacity of surfactant lipids.